NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move
Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...
1.6k Views
Yuhan Corp: (Part I) - Oversold on Hanmi Pharma Scares
Why Look atYuhan Corp?Yuhan Corp shares are quite interesting at current levels. It is currently trading at 214,000 won, which is down 38% (A...
1.4k Views
MediSetter Interview:Â Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
4.1k Views
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
3.6k Views
Korea Biotech & Healthcare: A Pair Trade Between Hanmi Science and Hanmi Pharm
In this insight, we discuss a pair trade between Hanmi Science (long) and Hanmi Pharm (short). There are three major reasons we like this pair trade.
693 Views